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eterminants of Cardiopulmonary Functional
mprovement After Transcatheter Atrial
eptal Defect Closure in Asymptomatic Adults
lessandro Giardini, MD,* Andrea Donti, MD,* Roberto Formigari, MD, FACC,*
alvatore Specchia, MD,† Daniela Prandstraller, MD,* Gabriele Bronzetti, MD,* Marco Bonvicini, MD,*
ernando M. Picchio, MD*
ologna, Italy
OBJECTIVES We sought to evaluate the course of cardiopulmonary function after transcatheter atrial septal
defect (ASD) closure and to identify the physiopathologic mechanisms leading to this change.
BACKGROUND Conflicting reports exist on cardiopulmonary functional improvement in asymptomatic adults
after transcatheter closure of a secundum ASD.
METHODS Thirty-two consecutive adults (13 males; age 42.6  16.7 years) underwent maximal
cardiopulmonary exercise testing and transthoracic echocardiography both on the day before
and six months after transcatheter ASD closure. Mean pulmonary artery pressure, pulmonary
to systemic flow ratio (Qp/Qs), and ASD diameter were measured before closure.
RESULTS Peak oxygen uptake (VO2) (p  0.001), peak oxygen pulse (p  0.0027), and vital capacity
(p  0.0086) improved after ASD closure, although peak heart rate did not. A significant
correlation was found between peak VO2 improvements and Qp/Qs (p  0.0013). Left
ventricular ejection fraction (LVEF) (p  0.0001) and left ventricular end-diastolic diameter
(LVEDD) (p  0.0001) significantly increased after six months, although left ventricular
end-systolic diameter did not. Right ventricular long- and short-axis dimensions decreased
(both p  0.0001). Peak VO2 and of peak oxygen pulse improvements correlated to both
LVEF (p  0.0009 and 0.0019, respectively) and LVEDD (p  0.0001 and 0.032,
respectively) increments. The decrease of both long- and short-axis right ventricular
dimensions positively correlated to both LVEF and LVEDD improvements. The improve-
ment in LVEF correlated to Qp/Qs (p  0.0026).
CONCLUSIONS Transcatheter ASD closure leads to a significant improvement in cardiopulmonary function
within six months, via an increase in peak oxygen pulse. An increase in both left ventricular
stroke volume and cardiac output due to a positive ventricular interaction is the mechanism
leading to improved peak VO2. (J Am Coll Cardiol 2004;43:1886–91) © 2004 by the
American College of Cardiology FoundationT
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Phe secundum atrial septal defect (ASD) is a common form
f congenital heart disease accounting for approximately
0% of all congenital cardiac defects (1). In children, it has
ong been accepted that elective surgical repair is the
reatment of choice if there is a considerable left-to-right
hunt, even in patients with few or no symptoms (2). On the
ther hand, no consensus exists for adults with an ASD who
See page 1892
ppear to be largely asymptomatic. Even though many
dults with an ASD claim to be asymptomatic or refer to
nly mild symptoms at rest, exercise capacity may be
ecreased (3) and symptoms can develop during exercise.
Surgical closure of an ASD has been practiced for more
han 45 years and, until recently, was considered the
tandard treatment for adult patients with an ASD (4,5).
From the *Pediatric Cardiology and Adult Congenital Unit and the †Institute of
ardiology, University of Bologna, Bologna, Italy.
Manuscript received August 4, 2003; revised manuscript received October 2, 2003,tccepted October 7, 2003.ranscatheter ASD closure has been increasingly used in
ecent years with high success rates (6,7) and with compli-
ation rates that compare rather favorably with surgical
epair (8,9), even in terms of a residual shunt (7) and
ormalization of right ventricular (RV) dimensions (10,11).
espite these remarkable results, only sparse and contrast-
ng data are available on improvement of cardiopulmonary
unction after elective percutaneous ASD closure (12,13).
urthermore, the physiopathologic mechanisms that inter-
ene in determining cardiopulmonary function improve-
ent after transcatheter ASD occlusion remain to be
dentified.
To search for factors and mechanisms that lead to an
mproved exercise capacity, we investigated the impact of
ercutaneous ASD closure on exercise capacity in a group of
symptomatic adults, along with the role of the left ventricle
LV) in exercise capacity improvement.
ETHODS
atients and study design. Between June 2001 and Sep-
ember 2002, a total of 32 consecutive “asymptomatic”
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May 19, 2004:1886–91 Device ASD Closure and Cardiopulmonary Functiondults underwent cardiopulmonary exercise testing and
ransthoracic echocardiography (TTE), both on the day
efore and six months after transcatheter ASD closure
mean age at closure: 42.6  16.7 years). Patient character-
stics are shown in Table 1, along with baseline transesoph-
geal echocardiographic (TEE) and right heart catheteriza-
ion findings. The study protocol consisted of a clinical
ssessment of functional capacity, according to the New
ork Heart Association (NYHA) functional class criteria,
nd cardiopulmonary exercise testing and TTE, both on the
ay before and six months after the procedure. Patients also
ad a complete hemodynamic evaluation via cardiac cathe-
erization just before closure of the defect. None of the
atients had additional coronary artery disease, valvular
eart disease, pulmonary disease, or an inability to exercise.
ardiopulmonary exercise test. Maximal cardiopulmo-
ary testing was performed on an ergometer cycle (Sensor-
edics, Yorba Linda, California). Peak oxygen uptake
VO2), carbon dioxide production, and minute ventilation
ere measured with a computerized breath-by-breath ana-
yzer (V-MAX 29, Sensor-Medics). Patients performed a
aximal exercise test using a 1-min incremental bicycle
rotocol with a work rate increment of 10 W/min. Criteria
or test ending were considered patient exhaustion or a
espiratory exchange ratio 1.09. A 12-lead electrocardio-
ram was also monitored throughout the study, and cuff
lood pressure was determined manually every 2 min.
efore exertion, a spirometric measurement was performed
o assess forced vital capacity (VC) and forced expiratory
Abbreviations and Acronyms
ASD  atrial septal defect
FEV1  forced expiratory volume in 1 s
LV  left ventricle/ventricular
LVEDD  left ventricular end-diastolic diameter
LVEF  left ventricular ejection fraction
LVESD  left ventricular end-systolic diameter
NYHA  New York Heart Association
Qp/Qs  pulmonary to systemic flow ratio
RV  right ventricle/ventricular
TEE  transesophageal echocardiography
TTE  transthoracic echocardiography
VC  vital capacity
VO2  oxygen uptake
able 1. Demographic, Echocardiographic, and Right Heart
atheterization Data (n  32)
ge at closure (yrs) 42.6  16.7 (18–77)
ale gender 13 (40%)
SD diameter at TEE (mm) 23.6  4.7 (12–32)
evice size (mm) median (range) 26 (18–34)*
p/Qs ratio 2.04  0.5 (1.3–3.3)
ean pulmonary artery pressure (mm Hg) 15.8  4.2 (9–25)
YHA functional class I 27 (84%)
ata are presented as the mean value  SD (range), number (%) of patients, or
median value (range).
ASD  atrial septal defect; NYHA  New York Heart Association; Qp/Qs 
bulmonary to systemic flow ratio; TTE  transthoracic echocardiography.olume in 1 s (FEV1). Standard equations were used to
enerate predicted values for baseline spirometric and peak
xercise parameters (14).
ransthoracic echocardiography. All 32 patients had
wo-dimensional color Doppler TTE on the day before and
ix months after ASD closure, using a Sonos 5500 ultra-
ound system (Agilent Technologies, Palo Alto, California).
he examination focused on the measurement of left
entricular end-diastolic diameter (LVEDD), left ventricu-
ar end-systolic diameter (LVESD), left ventricular ejection
raction (LVEF) (calculated according to the Teicholz
ethod), and left atrial diameter from the long-axis
arasternal view. Two measurements of the RV were made
n the apical four-chamber view: maximal RV long-axis
imension, defined as the distance between the RV apex
nd the mid-point of the tricuspid valve; and RV short-axis
imension, defined as the maximal dimension from the
ight septal surface to the free wall perpendicular to the long
xis. The parasternal long-axis view was used to evaluate the
resence of a paradoxical movement of the interventricular
eptum. Every measurement was done at least three times
nd averaged to obtain mean values. All patients were in
inus rhythm at the time of their echocardiographic
xaminations.
emodynamic study. Hemodynamic study and percuta-
eous closure were performed under general anesthesia with
ontinuous TEE monitoring. The size, location, and rela-
ionship of the defect to the surrounding structures were
ssessed by TEE. A margin of 5 mm between these
tructures and the ASD had to be present for the procedure
o be initiated. Pulmonary arterial and right and left atrial
ressures were obtained with standard fluid-filled catheters.
ith VO2 measured at rest, the pulmonary to systemic flow
atio (Qp/Qs) was calculated by oximetry, using the Fick
rinciple.
SD closure and follow-up. Closure of an ASD was
chieved in all patients with an Amplatzer (AGA Medical
orp., Golden Valley, Minnesota) device (median device
ize 26 mm [range 18 to 34 mm]). Angiography and TEE
erformed immediately after device deployment showed an
bsence of a residual shunt in 31 (96%) of 32 patients (the
atient with a periprocedural shunt was included in the
tudy group, as no residual shunt was noted on TTE after
ne month since closure). In two patients (ages 77 and 58
ears), pulmonary venous congestion developed a few hours
fter transcatheter closure and resolved within 24 h after
igh doses of diuretics. At TTE performed after six months,
o residual shunt was noted in the entire study group.
atients received six-month aspirin therapy and were ad-
ised to use antibiotic prophylaxis for endocarditis for six
onths after the procedure.
tatistical analysis. The Wilcoxon matched-pairs test was
sed to compare pre- versus post-ASD closure exercise test
nd TTE variables. Correlation coefficients were calculated
etween the variation (percent change from baseline) of
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Device ASD Closure and Cardiopulmonary Function May 19, 2004:1886–91ardiopulmonary test variables and hemodynamic, echocar-
iographic, and clinical variables. A value of p  0.05 was
onsidered significant.
ESULTS
ardiopulmonary exercise test. Data on the cardiopulmo-
ary test and TTE, both before and six months after ASD
losure, are shown in Table 2. Before the intervention, peak
O2 was moderately reduced with respect to the predicted
alues (61.6  17.4%), and 6 (18%) of 32 patients had a
evere reduction in peak VO2 (14 ml O2/kg/min; mean
1% of predicted values).
Overall, a significant improvement in peak VO2 (p 
.0001) was noted six months after the procedure. In particu-
ar, as shown in Figure 1, 29 patients (91%) showed improved
eak VO2 values after percutaneous closure. It is noteworthy
hat two of the three patients who did not improve had almost
ormal peak VO2 at baseline (77% and 104% of predicted
alues, respectively). Peak oxygen pulse had improved (p 
.0004) at six months after closure. Peak VO2 improvement
% from baseline) correlated to Qp/Qs magnitude (r2 0.30,
 0.0013) (Fig. 2), whereas no relation was noted with age
t closure (r2  0.0002, p  0.92), mean pulmonary artery
ressure (r2  0.0022, p  0.80), or ASD diameter measured
t TEE (r2  0.026, p  0.37). A nonsignificant increase in
eart rate was recorded at six months after the procedure (p
.08). No patient showed evidence of chronotropic impair-
ent (85% of maximal reference heart rate) or arrhythmias
uring follow-up.
omparison between subgroups. A Qp/Qs ratio 2 was
ound in 15 patients (47%) (median age at closure: 45.9
ears [range 20 to 70 years]; male/female ratio 0.6; median
p/Qs 1.5 [range 1.3 to 1.9]). The increase in peak VO2
Table 3) was significant both in patients 40 and 40
able 2. Mean Cardiopulmonary Test and Echocardiographic
alues Before and Six Months After Transcatheter Closure of
trial Septal Defect
Baseline 6 Months p Value*
C (l) 3.44  1.0 3.72  0.9 0.0086
EV1 (l/s) 2.79  0.83 2.98  0.86 0.088
eak VO2 (ml O2/kg/min) 21.9  10.3 25.6  9.9 0.0001
eak O2 pulse (ml O2/kg/beat) 8.9  2.81 10.2  3.7 0.0004
eak heart rate (beats/min) 155.8  21.7 157.4  19.1 0.086
VEDD (cm) 4.8  0.4 5.1  0.4 0.0001
VESD (cm) 3.0  0.4 3.1  0.4 0.19
VEF (%) 73.8  6.8 77.6  5.3 0.0001
A diameter (mm) 28.9  3.5 31.3  3.8 0.0001
VLA dimension (mm) 75.5  11.6 67.6  9.6 0.0001
VSA dimension (mm) 36.2  6.3 30.5  6.0 0.0001
Compared by the Wilcoxon matched-pairs test. Data are presented as the mean value
SD.
ASD atrial septal defect; FEV1 forced expired volume in 1 s; LA left atrial;
VEDD  left ventricular end-diastolic diameter; LVEF  left ventricular ejection
raction; LVESD  left ventricular end-systolic diameter; RVLA  right ventricular
ong-axis; RVSA  right ventricular short-axis; VC  vital capacity; VO2  oxygen
ptake.ears of age at percutaneous closure (19% and 27%, tespectively), as well as in those with a Qp/Qs ratio 2 or
2 (22% and 26%, respectively).
unctional status. Before closure, 27 (84%) of 32 patients
ere self-perceived as being in NYHA functional class I,
espite a moderate reduction in cardiopulmonary function,
hereas the remaining five were in NYHA class II. At six
onths from closure, no patient reported a change in
YHA functional class.
pirometric test. Before the intervention, the mean values
or VC and FEV1 at rest were still within the normal range
85.8  10.5% and 90.9  9.7%, respectively). Six months
fter transcatheter ASD closure, a significant improvement
igure 2. Correlation between the change in peak oxygen uptake (VO2)
nd magnitude of pulmonary to systemic flow ratio (Qp/Qs). A significant
orrelation exists between Qp/Qs magnitude and cardiopulmonary func-
igure 1. Peak oxygen uptake (VO2) at baseline and six months after the
rocedure.ional improvement after transcatheter atrial septal defect closure.
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May 19, 2004:1886–91 Device ASD Closure and Cardiopulmonary Functionas observed for VC (p  0.0086) but not for FEV1 (p 
.08).
ransthoracic echocardiography. As shown in Table 2, at
ix months after transcatheter ASD closure, significant
ncreases in LVEF (p 0.0001) and LVEDD (p 0.0001)
ere noted in the overall population, whereas LVESD had
ot changed significantly from baseline (p  0.19). Peak
O2 increments (%), with respect to baseline values,
orrelated to both LVEF (r2  0.31, p  0.0009) and
VEDD (r2  0.49, p  0.0001) increments from baseline
able 3. Peak Oxygen Uptake at Baseline and Six Months
fter Atrial Septal Defect Closure for Different Subgroups
Baseline Peak VO2
(ml O2/kg/min)
6-Month Peak VO2
(ml O2/kg/min) p Value*
ge 40 yrs 29.0  12.1 33.1  11.4 0.0029
ge 40 yrs 17.6  5.8 21.0  5.4 0.0003
p/Qs ratio 2 18.8  5.7 22.1  5.7 0.0002
p/Qs ratio 2 25.2  13.0 29.4  12.2 0.0006
Compared by the Wilcoxon matched-pairs test. Data are presented as the mean value
SD.
Abbreviations as in Tables 1 and 2.
igure 3. Correlation between transthoracic echocardiography and cardio
ignificant association exists between postprocedural changes in peak oxyge
eft ventricular end-diastolic diameter (LVEDD) (b). A similar significant
xygen (O2) pulse variations from baseline.Fig. 3), but not with LVESD variation (r2  0.027, p 
.43). Similarly, pulse oxygen variation (%) from baseline
orrelated to LVEF (r2 0.28, p 0.0019) and, in a barely
ignificant fashion, with LVEDD (r2  0.14, p  0.032)
ariations (Fig. 3), but not with LVESD variation (r2 
.0021, p 0.8). A correlation (r2 0.26, p 0.0026) was
oted between improvement in LVEF achieved at six
onths from transcatheter ASD closure and the magnitude
f a left-to-right shunt (Fig. 4). The left atrial diameter was
ignificantly increased at six months after the intervention (p
0.0001) (Table 2).
The RV long- and short-axis dimensions significantly
ecreased six months after closure (p  0.0001 and p 
.0001, respectively) (Table 2). Moreover, the percent
ecrease in both RV long- and short-axis dimensions noted
fter closure correlated to both LVEF improvement (r2 
.53, p  0.0001 and r2  0.40, p  0.0001, respectively)
nd LVEDD increase (r2  0.35, p  0.0004 and r2 
.59, p  0.0001, respectively). A paradoxical movement of
he interventricular septum was present in 17 (53%) of 32
onary testing variables after transcatheter atrial septal defect closure. A
ake (VO2) and changes in left ventricular ejection fraction (LVEF) (a) and
lation was found between LVEF (c) and LVEDD (d) changes and peakpulm
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Device ASD Closure and Cardiopulmonary Function May 19, 2004:1886–91atients at baseline and in 3 (9%) of 32 patients at six
onths after closure (p  0.0003 by the Fisher exact test).
ISCUSSION
his prospective study provides strong evidence that in
asymptomatic” adults, transcatheter ASD closure leads to a
ignificant increase in peak VO2 within six months. More-
ver, the correlation found between the extent of peak VO2
mprovement after transcatheter ASD closure and Qp/Qs
agnitude (Fig. 2) suggests that patients with larger left-
o-right shunts stand to gain the greatest benefits from
ranscatheter closure. Our data also suggest that the im-
rovement of peak VO2 after closure is probably a conse-
uence of increased LV stroke volume and cardiac output.
Our TTE findings, showing significantly increased
VEDD and LVEF and unchanged LVESD after the
rocedure, suggest that an increase in LV stroke volume
ccurs after transcatheter ASD closure, ultimately leading to
ncreased systemic cardiac output. Accordingly, as no
hange was found in maximal heart rate, the improvement
n peak VO2 after transcatheter ASD closure seems to depend
n a significantly increased peak oxygen pulse (Table 3), which
s an indirect marker of LV stroke volume. These observations
re supported by the observations of significant correlations
etween improvements in peak cardiopulmonary exercise test
ariables (VO2 and oxygen pulse) and increases in both LVEF
nd LVEDD, which were induced by ASD closure.
On physiopathologic grounds, our data suggest that the
bolishment of left-to-right shunting after ASD closure
ugments LV volume filling, thereby increasing LV preload,
VEDD, LVEF, and, ultimately, LV stroke volume.
ence, the rise in LV stroke volume can explain the increase
n peak oxygen pulse, and—given the unchanged maximal
eart rate—the increased LV cardiac output can explain the
ncrease in peak VO2. Furthermore, the correlation noted
etween Qp/Qs magnitude and LVEF improvement after
losure (Fig. 4) indicates that the magnitude of improve-
igure 4. Correlation between magnitude of pulmonary to systemic flow
atio (Qp/Qs) and left ventricular ejection fraction (LVEF) improvement
fter transcatheter atrial septal defect closure.ent in LV systolic function seems to depend on the entity if the left-to-right shunt. However, a limited subgroup of
symptomatic patients with a low Qp/Qs ratio (2) showed
significant increase in cardiopulmonary function, thus
uggesting that even a low-magnitude atrial shunt may have
n effect on exercise capacity.
This hypothesis is in accordance with published data on
he reduction of RV volume overload after shunt closure and
V volume unloading induced by ASD closure (10,11).
oreover, the acute increase in LV filling after ASD closure
ay explain the observation, in both the present series and
ther studies (15), that a minority of patients experience
ulmonary edema within a few hours of transcatheter ASD
losure. The majority of these patients are elderly and
ypertensive and have a hypertrophied, less compliant LV
hat can hardly cope with an acute increase of preload. We
bserved a significant dilation of the left atrium (p 
.0001) after defect closure, which may indicate an increase
n atrial wall tension induced by an acute increase of
entricular diastolic and atrial pressures.
Our data strongly indicate that, six months after closure,
ong- and short-axis dimensions of the RV chamber are
ignificantly decreased compared with baseline values (p 
.0001 and p  0.0001, respectively), and the magnitude of
he reduction of RV dimensions after blood volume unload-
ng both positively and significantly correlates to improve-
ent in LVEDD and in LVEF. Furthermore, the paradox-
cal movement of the interventricular septum disappeared in
significant percentage of patients, possibly causing an
ncrease in LV stroke volume. These results suggest that an
mproved ventricular interaction induced by shunt abolish-
ent probably plays a central role in the improvement of
eak VO2 and cardiac output.
Conflicting data have recently emerged on recovery of
xercise capacity, expressed by peak VO2 after transcatheter
SD closure (12,13). Our results indicate that a highly
ignificant improvement in cardiopulmonary function oc-
urs within six months of closure in most patients, irrespective
f age at closure, defect size, and mean pulmonary artery
ressure. Our findings are in keeping with those of Brochu et
l. (12), who recently reported a significant increase in peak
O2 after ASD closure. It should be noted, however, that their
tudy lacked a comprehensive analysis of important cardiopul-
onary test variables other than peak VO2, which could have
ccounted for the reported improvement. In contrast, in a small
roup of patients, Rhodes et al. (13) were unable to find any
mprovement in peak VO2 at two months after percutaneous
SD closure. Their negative findings might have several
xplanations, including the rather young age of their patients
median 13 years [range 7 to 48 years]), which could be
ssociated with less severe cardiopulmonary functional impair-
ent. Moreover, the almost normal preclosure peak VO2 values
ecorded by Rhodes and associates would have made further
mprovement less likely. Interestingly, two patients in our study
ho had normal cardiopulmonary function before ASD clo-
ure did not show any improvement at six months after the
ntervention. A further explanation for the discrepancy might
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May 19, 2004:1886–91 Device ASD Closure and Cardiopulmonary Functione that the beneficial effect of transcatheter closure on cardio-
ulmonary function could take more than two months to
ecome apparent.
Another major finding of the present study is that
lthough uncomplicated ASD was well tolerated in our
symptomatic adults, despite high pulmonary blood flow
nd right heart volume overload, cardiopulmonary function
as markedly impaired. Our patients had moderately im-
aired peak VO2 values before closure (61.6  17.4% of
redicted values), despite normal pulmonary artery pressure
t rest (Table 1). This finding reveals a discrepancy between
elf-assessed exercise tolerance in everyday life and objective
ardiopulmonary function. This might be ascribed to pa-
ients’ limiting their behavior according to their functional
bility. Interestingly, before closure, 27 patients (84%)
hought they belonged to NYHA functional class I (despite
moderate reduction in cardiopulmonary function),
hereas the remaining five thought they were in class II; at
ix months from closure, none of the patients subjectively
oted a change in NYHA functional class.
Regarding ventilatory function, the mean VC and FEV1
alues of our patients before ASD closure were in the lower
art of the normal range, in keeping with reports by De
royer et al. (16) and Helber et al. (17), who found only
ildly reduced values in adults with nonrestrictive ASD. As
uggested (16), these findings may be possibly due to
ompetition for space between the intrapulmonary blood
essels and small airways, leading to narrowing of the
ronchiole and increased air resistance. Nevertheless, six
onths after percutaneous closure, we observed a significant
ncrease in VC, but not in FEV1. The improvement in VC
ight be related to abolishment of the upstream left-to-
ight shunt and of pulmonary vessel overload, with a
ecrease in water content in the lungs (17). In contrast to
revious reports (8,18), no patient experienced arrhythmias
uring follow-up or during the exercise test performed at six
onths.
tudy limitations. Despite the prospective character of the
tudy, the limited sample size (n  32) requires further
onfirmation of our findings in a larger ASD patient
opulation. Therefore, our data need to be interpreted in
he light of the patients’ individual characteristics (Table 1).
onclusions. This study strongly suggests that transcath-
ter ASD closure leads to a significant improvement of peak
O2 within six months via an increase of peak oxygen pulse.
fter ASD closure, LVEF and LVEDD, but not LVESD,
ere significantly increased, thus producing an increase in
V stroke volume, as reflected by a concomitant improve-
ent in peak oxygen pulse. The RV end-diastolic long- and
hort-axis dimensions significantly decreased after defect
losure, and the magnitude of this reduction positively
orrelated to improvement of LVEDD and LVEF. The
agnitude of peak VO2 and LVEF improvement is signif-cantly correlated to the Qp/Qs ratio. Maximal heart rateas not significantly increased at six months after closure.
hus, the mechanism responsible for peak VO2 improve-
ent after ASD closure seems to be an increase of LV
utput due to increased volume loading of the LV, as well as
o an improved ventricular interaction.
eprint requests and correspondence: Dr. Alessandro Giardini,
ediatric Cardiology and Adult Congenital Unit, University of
ologna, Via Massarenti 9, Bologna, 40138 Italy. E-mail:
lessandro5574@iol.it.
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